Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence

S B Ho1, S L Ewing, C K Montgomery

  • 1Departments of Medicine and Pathology, University of Minnesota, and VA Medical Center, Minneapolis 55417, USA.

Oncology Research
|January 1, 1996
PubMed
Summary

Altered mucin glycosylation in colonic polyps, specifically MUC1, MUC2, and MUC3, correlates with malignant potential. Enhanced protein expression in adenomas indicates increased risk for cancer transformation.